- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05546346
Clinical Application of Wearable Magnet Tracking System for Capsule Endoscopes
October 16, 2024 updated by: Qilu Hospital of Shandong University
The investigators developed a wearable magnet tracking system, which provided a non-invasive and high accuracy method for capsule endoscopes localization.
Data fusion from multiple sensors expanded positioning range and proposed localization algorithm overcame shortcomings of existing systems.
This clinical trial was conducted to verify effectiveness and stability of the tracking system.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jingran Su, PhD
- Phone Number: 18769787193
- Email: taylor1943@163.com
Study Locations
-
-
Shandong
-
Jinan, Shandong, China
- Recruiting
- Qilu Hospital of Shandong University
-
Contact:
- Jingran Su, PhD
- Phone Number: 18769787193
- Email: taylor1943@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- aged between 18 and 75
- agree to give written informed consent
Exclusion Criteria:
- dysphagia or symptoms of gastric outlet obstruction, suspected or known intestinal stenosis, overt gastrointestinal bleeding, history of upper gastrointestinal surgery or abdominal surgery altering gastrointestinal anatomy, or postabdominal radiation
- congestive heart failure, renal insufficiency, under therapeutic anticoagulation, in poor general condition (American Society of Anesthesiologists class III/IV), claustrophobia, metallic parts, a pacemaker or other implanted electromedical devices, or artificial heart valves
- pregnancy or suspected pregnancy
- exclusion criteria for standard magnetic resonance imaging examination such as the presence of surgical metallic devices, even though its low magnetic field technically would not interferewith such devices
- currently participating in another clinical study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: wearable magnet tracking system
|
In this group, wearable magnet tracking system was used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The duration of time
Time Frame: 12 months
|
the length of time of the tracking system used in continuous acquisition of the magnetic field strength values
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 30, 2023
Primary Completion (Estimated)
October 30, 2025
Study Completion (Estimated)
October 30, 2025
Study Registration Dates
First Submitted
September 15, 2022
First Submitted That Met QC Criteria
September 16, 2022
First Posted (Actual)
September 19, 2022
Study Record Updates
Last Update Posted (Actual)
October 18, 2024
Last Update Submitted That Met QC Criteria
October 16, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2022SDU-QILU-827
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Capsule Endoscopes
-
Taipei Veterans General Hospital, TaiwanUnknown
-
Changhai HospitalNot yet recruitingAcute Upper Gastrointestinal Bleeding | Capsule EndoscopesChina
-
Queen's UniversityHotel Dieu Hospital (Gastrointestinal Diseases Research Unit)CompletedQuality of Bowel Preparation for the Colon Capsule | Colon Capsule Completion Rates | Colon Capsule Polyp DetectionCanada
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityUnknownCataract | Posterior Capsule OpacificationChina
-
Hanita LensesRecruitingPosterior Capsule OpacificationIsrael
-
Sohag UniversityRecruitingPosterior Capsule OpacificationEgypt
-
Prim. Prof. Dr. Oliver Findl, MBAUnknownPosterior Capsule OpacificationAustria
-
Minia UniversityCompletedPosterior Capsule OpacificationSaudi Arabia
-
Sun Yat-sen UniversityUnknownPosterior Capsule OpacificationChina
-
Sun Yat-sen UniversityUnknownCataract | Posterior Capsule OpacificationChina
Clinical Trials on wearable magnet tracking system
-
Brigham and Women's HospitalWithdrawnCardiac Surgery | Enhanced Recovery
-
GT Metabolic Solutions, Inc.Not yet recruiting
-
GT Metabolic Solutions, Inc.RecruitingColorectal | Anastomosis, FunctionalChile, Italy
-
GT Metabolic Solutions, Inc.RecruitingSmall Bowel Obstruction | Gastric Outlet Obstruction | Superior Mesenteric Artery SyndromeCanada
-
GT Metabolic Solutions, Inc.RecruitingType 2 Diabetes (T2DM) | Obesity (Disorder) | Obesity & OverweightCanada
-
Dr Falk Mueller-RiemenschneiderUnknown
-
Tel-Aviv Sourasky Medical CenterOwlytics HealthcareRecruiting
-
Sensible Medical Innovations Ltd.Terminated
-
Lisa BrennerApollo NeuroscienceCompleted
-
University of Kansas Medical CenterSan Diego State University; University of Michigan; DARTNet Institute; Global Health...Active, not recruiting